The IIN has partnered with Nanyang Technological University (NTU), Singapore, to establish a $70 million institute to support research into nanomedicine.
The NTU-NU Nanomedicine Institute supports scientists from both institutions working collaboratively on research projects in the areas of disease diagnostics, timed-release therapeutics, and targeted drug delivery methods, which would greatly increase the efficacy of existing drugs and therapies, while enabling earlier and more rapid detection of diseases. Researchers will also design new methodologies, such as gene silencing and theranostics, to treat diseases, with emphasis on cardiovascular, ocular, skin, and endocrinological disease.
The Executive Committee for this new Institute is currently reviewing proposals for funding and information about the funded research efforts will be available on this site as soon as awards are made.
The innaugural NTU-NU Nanomedicine Institute Workshop will be held Sunday, December 20 through Monday, December 21 in Lahaina, Maui, Hawaii. The Symposium offers an opportunity for key leadership and researchers in the NTU-NU Nanomedicine Institute to present updates on research and stregthen collaborations. Please note that this event is open to NTU-NU Nanomedicine Institute members only.
Sign up for our newsletter to receive information on events, news, and articles.